Patients with Duchenne muscular dystrophy are significantly shorter than those with Becker muscular dystrophy, with the higher incidence of short stature in Dp71 mutated subgroup

Neuromuscul Disord. 2017 Nov;27(11):1023-1028. doi: 10.1016/j.nmd.2017.06.007. Epub 2017 Jun 19.

Abstract

Duchenne and Becker muscular dystrophy (DMD/BMD) are caused by mutations in the dystrophin gene and are characterized by severe and mild progressive muscle wasting, respectively. Short stature has been reported as a feature of DMD in the Western hemisphere, but not yet confirmed in Orientals. Height of young BMD has not been fully characterized. Here, height of ambulant and steroid naive Japanese 179 DMD and 42 BMD patients between 4 and 10 years of age was retrospectively examined using height standard deviation score (SDS). The mean height SDS of DMD was -1.08 SD that was significantly smaller than normal (p < 0.001), indicating short stature of Japanese DMD. Furthermore, the mean height SDS of BMD was -0.27 SD, suggesting shorter stature than normal. Remarkably, the mean height SDS of DMD was significantly smaller than that of BMD (p < 0.0001). In DMD higher incidence of short stature (height SDS < -2.5 SD) was observed in Dp71 subgroup having mutations in dystrophin exons 63-79 than others having mutations in exons 1-62 (27.8% vs. 7.5%, p = 0.017). These suggested that height is influenced by dystrophin in not only DMD but also BMD and that dystrophin Dp71 has a role in height regulation.

Keywords: Becker muscular dsytrophy; Dp71; Duchenne muscular dystrophy; Dystrophin; Isoform; Short stature.

Publication types

  • Comparative Study

MeSH terms

  • Age Factors
  • Body Height / genetics*
  • Body Mass Index
  • Child
  • Child, Preschool
  • Dystrophin / genetics*
  • Follow-Up Studies
  • Humans
  • Incidence
  • Male
  • Muscular Dystrophy, Duchenne / epidemiology*
  • Muscular Dystrophy, Duchenne / genetics*
  • Mutation*
  • Retrospective Studies

Substances

  • Dystrophin
  • apo-dystrophin 1